New York State Common Retirement Fund’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-320,856
| Closed | -$78.8M | – | 3268 |
|
|
2022
Q3 | $78.8M | Sell |
320,856
-1,480
| -0.5% | -$400K | 0.11% | 163 |
|
|
2022
Q2 | $79.8M | Sell |
322,336
-2,198
| -0.7% | -$593K | 0.1% | 175 |
|
|
2022
Q1 | $107M | Buy |
324,534
+116,400
| +56% | +$35.8M | 0.12% | 160 |
|
|
2021
Q4 | $74.8M | Sell |
208,134
-1,873
| -0.9% | -$633K | 0.08% | 228 |
|
|
2021
Q3 | $68.4M | Sell |
210,007
-36,356
| -15% | -$12.3M | 0.07% | 245 |
|
|
2021
Q2 | $76.9M | Sell |
246,363
-1,143
| -0.5% | -$351K | 0.08% | 226 |
|
|
2021
Q1 | $78.9M | Sell |
247,506
-9,300
| -4% | -$2.98M | 0.09% | 210 |
|
|
2020
Q4 | $83.3M | Sell |
256,806
-4,500
| -2% | -$1.24M | 0.09% | 205 |
|
|
2020
Q3 | $72.4M | Sell |
261,306
-7,100
| -3% | -$2.05M | 0.09% | 212 |
|
|
2020
Q2 | $64.8M | Sell |
268,406
-5,700
| -2% | -$1.14M | 0.08% | 225 |
|
|
2020
Q1 | $39.8M | Sell |
274,106
-41,300
| -13% | -$6.86M | 0.06% | 296 |
|
|
2019
Q4 | $53.8M | Sell |
315,406
-9,829
| -3% | -$1.82M | 0.06% | 280 |
|
|
2019
Q3 | $57.9M | Buy |
325,235
+70,698
| +28% | +$15.3M | 0.07% | 260 |
|
|
2019
Q2 | $66.3M | Buy |
254,537
+10,926
| +4% | +$2.9M | 0.08% | 233 |
|
|
2019
Q1 | $69.6M | Sell |
243,611
-7,749
| -3% | -$2.58M | 0.09% | 223 |
|
|
2018
Q4 | $81.7M | Sell |
251,360
-1,600
| -0.6% | -$556K | 0.12% | 169 |
|
|
2018
Q3 | $114M | Sell |
252,960
-13,828
| -5% | -$5.45M | 0.13% | 148 |
|
|
2018
Q2 | $109M | Sell |
266,788
-34,795
| -12% | -$12.6M | 0.14% | 148 |
|
|
2018
Q1 | $87.8M | Sell |
301,583
-4,445
| -1% | -$1.13M | 0.11% | 189 |
|
|
2017
Q4 | $57.4M | Sell |
306,028
-7,562
| -2% | -$1.41M | 0.07% | 284 |
|
|
2017
Q3 | $52.9M | Buy |
313,590
+5,719
| +2% | +$865K | 0.07% | 288 |
|
|
2017
Q2 | $44.1M | Buy |
307,871
+75,200
| +32% | +$10.1M | 0.06% | 329 |
|
|
2017
Q1 | $29.1M | Buy |
232,671
+36,700
| +19% | +$4.25M | 0.04% | 471 |
|
|
2016
Q4 | $22.1M | Sell |
195,971
-4,569
| -2% | -$529K | 0.03% | 575 |
|
|
2016
Q3 | $25.8M | Buy |
200,540
+8,225
| +4% | +$985K | 0.04% | 498 |
|
|
2016
Q2 | $21M | Buy |
192,315
+54,870
| +40% | +$5.46M | 0.03% | 580 |
|
|
2016
Q1 | $13M | Buy |
137,445
+70,306
| +105% | +$5.93M | 0.02% | 778 |
|
|
2015
Q4 | $6.06M | Sell |
67,139
-4,645
| -6% | -$394K | 0.01% | 1137 |
|
|
2015
Q3 | $6.66M | Sell |
71,784
-23,399
| -25% | -$2.06M | 0.01% | 1098 |
|
|
2015
Q2 | $6.26M | Buy |
95,183
+2,491
| +3% | +$166K | 0.01% | 1222 |
|
|
2015
Q1 | $6.63M | Buy |
92,692
+23,192
| +33% | +$1.26M | 0.01% | 1059 |
|
|
2014
Q4 | $2.65M | Hold |
69,500
| – | – | ﹤0.01% | 1504 |
|
|
2014
Q3 | $1.73M | Sell |
69,500
-15,400
| -18% | -$390K | ﹤0.01% | 1685 |
|
|
2014
Q2 | $2.13M | Buy |
84,900
+1,000
| +1% | +$23.3K | ﹤0.01% | 1634 |
|
|
2014
Q1 | $2.19M | Buy |
83,900
+1,000
| +1% | +$27.7K | ﹤0.01% | 1612 |
|
|
2013
Q4 | $2.22M | Buy |
82,900
+900
| +1% | +$22.2K | ﹤0.01% | 1592 |
|
|
2013
Q3 | $1.56M | Hold |
82,000
| – | – | ﹤0.01% | 1643 |
|
|
2013
Q2 | $1.77M | Buy |
+82,000
| New | +$1.65M | ﹤0.01% | 1492 |
|
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
New York State Common Retirement Fund's ABMD Position: Q4 2022 in Review
New York State Common Retirement Fund sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 320,856 shares — an estimated $78.8M sold.
New York State Common Retirement Fund first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $114M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- New York State Common Retirement Fund reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- New York State Common Retirement Fund sold 320,856 Abiomed Inc shares in Q4 2022, an estimated $78.8M.
- New York State Common Retirement Fund first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
- New York State Common Retirement Fund's Abiomed Inc position peaked at $114M in Q3 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on New York State Common Retirement Fund's 13F filing for Q4 2022, filed 30 Jan 2023.